ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,487.40
0.12%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Olema Pharmaceuticals Inc (OLMA)

  7. Olema Pharmaceuticals Inc (OLMA) 뉴스

OLMA Olema Pharmaceuticals Inc

9.48
-0.35 (-3.56%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Olema Pharmaceuticals Inc OLMA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.35 -3.56% 9.48 08:13:09
개장가 저가 고가 종가 전일 종가
9.87 9.51 10.09 9.95 9.83
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202405:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
03/04/202405:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
12/03/202405:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/03/202405:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/03/202405:05EDGAR2Form 8-K - Current report
12/03/202405:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
06/03/202421:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
05/03/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01/03/202404:26EDGAR2Form 144 - Report of proposed sale of securities
15/02/202406:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202402:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202407:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
06/02/202421:01GLOBEOlema Oncology to Participate in Upcoming Investor..
06/02/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
02/02/202405:24EDGAR2Form 144 - Report of proposed sale of securities
01/02/202406:21EDGAR2Form S-3 - Registration statement under Securities Act of..
01/02/202404:58EDGAR2Form 144 - Report of proposed sale of securities
29/01/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202423:07EDGAR2Form 8-K - Current report
08/01/202422:18EDGAR2Form 8-K - Current report
08/01/202422:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
06/01/202407:26EDGAR2Form 8-K - Current report
06/01/202407:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/01/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:01GLOBEOlema Oncology to Present at 42nd Annual J.P. Morgan..
30/12/202305:54EDGAR2Form 144 - Report of proposed sale of securities
19/12/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202310:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202310:30EDGAR2Form 3/A - Initial statement of beneficial ownership of..
06/12/202321:48EDGAR2Form 8-K - Current report
06/12/202307:15EDGAR2Form 8-K - Current report
06/12/202302:27GLOBEOlema Oncology Announces Palazestrant Demonstrates..
05/12/202306:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
02/12/202307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202300:20EDGAR2Form 144 - Report of proposed sale of securities
29/11/202307:10GLOBEOlema Oncology to Present New Palazestrant Clinical Data in..
23/11/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202305:25EDGAR2Form 144 - Report of proposed sale of securities
23/11/202305:04EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
OLMA
Olema Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유